MIRA INFORM REPORT

 

 

Report Date :

13.07.2013

 

IDENTIFICATION DETAILS

 

Name :

DSM SINOCHEM PHARMACEUTICALS INDIA PRIVATE LIMITED

 

 

Formerly Known As :

DSM ANTI INFECTIVES INDIA LIMITED

 

 

Registered Office :

Bhai Mohan Singh Nagar, Toansa, Tehsil Balachaur, District Nawanshahr, Ludhiana – 144533, Punjab

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

19.01.1993

 

 

Com. Reg. No.:

16-023090

 

 

Capital Investment / Paid-up Capital :

Rs. 1603.010 Millions

 

 

CIN No.:

[Company Identification No.]

U24231PB1993PTC023090

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

JLDD01636F

 

 

PAN No.:

[Permanent Account No.]

AABCM4314K

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Bulk Drugs and Intermediate Products.

 

 

No. of Employees :

Not Divulged

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (27)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 4830000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having a moderate track record. The company has been incurring loss from its operations past some years and hence there appear huge accumulated losses recorded by the company. However, trade relations are reported to be fair. Business is active. Payments are reported to be slow but correct.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION DECLINED BY

 

Name :

Ms. Malwika

Designation :

HR Executive

Contact No.:

91-1881-509650

Date :

12.07.2013

 

 

LOCATIONS

 

Registered Office/ Factory :

Bhai Mohan Singh Nagar, Toansa, Tehsil Balachaur, District Nawanshahr, Ludhiana – 144533, Punjab, India

Tel. No.:

91-1881-509650/ 273624/ 6

Fax No.:

91-1881-509890

E-Mail :

komal.gupta@dsm.com

anil.sharma@dsm.com

Website :

http://www.dsm.com

 

 

Corporate/ Branch Office 1 :

9th Floor, Tower A, Infinity Towers, DLF Phase II Gurgaon – 122002, Haryana,  India

Tel. No.:

91-124-4179900

 

 

Branch Office 2 :

Plot No.E57 and E58, Additional MIDC, Anandnagar, Ambernath (East), Thane - 421501, Maharashtra, India

Tel. No.:

91-251-6484018

 

 

Branch Office 3 :

Windsor House, 401 Fourth Floor, CST Road, Kalina, Santacruz (East), Mumbai – 400098, Maharashtra, India

Tel. No.:

91-22-40349100

 

 

Branch Office 4 :

401/402, 4th Floor, NSG IT Park, Aundh, Pune – 411007, Maharashtra, India

Tel. No.:

91-20-66430800

 

 

Branch Office 5 :

Plot No. F 40, Ranjangaon MIDC, Tal. Shirur, Ranjangaon – 412220, Maharashtra, India

 

 

Branch Office 6 :

Unit 3, 9th Floor, Building # 20 (Zenon), Sundew Properties Private Limited, IT and ITES - SEZ, K Raheja Mindspace IT Park, Hitech City, Madhapur, Hyderabad – 500081, Andhra Pradesh, India

Tel. No.:

91 40 4949 4000

 

 

Branch Office 7 :

Unit No 407, Barton Center, 4th Floor, No 84, MG Road, Bangalore – 560001, Karnataka, India

 

 

Branch Office 8 :

Global Axis, Plot No. 152, Gopalan Enterprises SEZ, EPIP Area, Bangalore – 560069, Karnataka, India

Tel. No.:

91-80-67255000

 

 

DIRECTORS

 

AS ON 26.09.2012

 

Name :

Mr. Vineet Kumar Singhal

Designation :

Whole-time director

Address :

Flat No. 1303, Tower 5, The Palms South City 1, Gurgaon – 122001, Haryana, India

Date of Birth/Age :

20.11.1972

Date of Appointment :

03.07.2012

PAN No.:

AIGPS2799L

DIN No.:

00552569

 

 

Name :

Bartholomeus Joannes Josephus Vincentius Welten

Designation :

Director

Address :

25 Oxley Walk #02-22 Belle Vue Residences Singapore 238595

Date of Birth/Age :

06.10.1960

Date of Appointment :

24.05.2013

DIN No.:

06615396

 

 

Name :

Mr. Vikas Mittal

Designation :

Director

Address :

H. No. 134, Old Housing Boaard Colony, Panipat – 132103, Haryana, India

Date of Birth/Age :

27.02.1977

Date of Appointment :

11.05.2012

DIN No.:

05286146

 

 

KEY EXECUTIVES

 

Name :

Ms. Malwika

Designation :

HR Executive

 

 

Name :

Ms. Komal Sachin Gupta

Designation :

Secretary

Address :

F 102, Bestech Park View City II, Sohna Road, Near Omaxe Mall, Gurgaon – 122001, Haryana, India

Date of Birth/Age :

25.03.1983

Date of Appointment :

30.04.2010

PAN No.:

BHAPS5283H

 

 

Name :

Bharat R Sesha

Designation :

Vice President

Date of Birth/Age :

40 Years

Qualification :

BE, MBA MIM

Experience :

11 Years

 

 

Name :

Deepak Chander

Designation :

Business Head

Date of Birth/Age :

39 Years

Qualification :

B. Tech Chemistry Engg from IIT Delhi, MBA Mktg & Strategy from IIM Indore

Experience :

16 Years

 

 

Name :

Giel Tan Haaf

Designation :

Director Finance

Date of Birth/Age :

37 Years

Qualification :

Masters of Science, Executive Masters of Finance & Control

Experience :

10 Years

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 26.09.2012

 

Names of Shareholders

 

No. of Shares

Gist Brocades International, B.V, Netherlands

 

160300676

Pranesh Sridharan (held as nominee for Gist Brocades International, B.V, Netherlands)

 

5

Vineet Kumar Singhal (held as nominee for Gist Brocades International, B.V, Netherlands)

 

5

Aanchal Singh (held as nominee for Gist Brocades International, B.V, Netherlands)

 

2

Somen Ganguly (held as nominee for Gist Brocades International, B.V, Netherlands)

 

2

Rajesh Salwan (held as nominee for Gist Brocades International, B.V, Netherlands)

 

2

Vikas Mittal (held as nominee for Gist Brocades International, B.V, Netherlands)

 

4

 

 

 

Total

 

160300696

 

 

AS ON 26.09.2012

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]

 

100.00

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Bulk Drugs and Intermediate Products.

 

 

Products :

ITC Code

Product Descriptions

294110

Amoxicillin Trihydrate

294110

Ampicillin Trihydrate

294110

Cloxacillin Sodium

 

 

Exports :

Not Divulged

 

 

Imports :

Not Divulged

 

 

PRODUCTION STATUS AS ON (31.03.2011)

 

Particulars

Unit

Licensed Capacity

Installed Capacity

Actual Production

Intermediates

MT

NA

2160

608.96

Bulk Drugs

MT

NA

4080

3990.10

 

Notes: -

 

1.       Installed capacity, being a technical matter, has been certified by the management and accepted by the Auditors. Installed capacities are as on 31st March, 11.

 

2.       Actual production includes 558.00 MTs (Previous year 925.94 MTs) of Intermediates used for captive consumption.

 

3.       Production includes job work production of 14.44 MTs (Previous year Nil) of bulk drugs and 15.48 MTs of intermediate (Previous year 231.14 MTs). Out of 15.48 MTs of intermediates 15.48 MTs were captively consumed.

 

 

GENERAL INFORMATION

 

Suppliers :

Not Divulged

 

 

Customers :

Not Divulged

 

 

No. of Employees :

Not Divulged

 

 

Bankers :

Not Available

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

S. R. Batliboi and Company

Chartered Accountants

Address :

Hindustan Times Building, 18-20 Kasturba Gandhi Marg, 6th Floor, New Delhi - 110001, India

Income-tax PAN of auditor or auditor's firm :

AALFS0506L

 

 

Holding company :

Gist Brocades International B.V.

 

 

Ultimate Holding company :

DSM Sinochem Pharmaceuticals Limited

 

 

Joint Ventures

Hindustan Max GB Limited, Pune [U24232PN1995PLC017954]

 

 

Enterprises which are owned, or have significant influence of or are partners

with Key management personnel and their relatives :

v      DSM Sinochem Pharmaceuticals BV

v      Zhangjiakou Gist-Brocades Pharmaceuticals Company Limited, China (ZGB, China)

v      DSM Trading (Shanghai) Company Limited, Hongkong

v      DSM NV Concern, The Netherlands (DSM NV)

v      DSM Finance, The Netherlands

v      DSM Food Specialties Products

v      DSM Nutritional Products, The Netherlands

v      DSM Nutritional Products, India

v      DSM Anti-Infectives, Egypt (DAI Egypt) S. A.E.

v      DSM Anti–Infectives, Egypt L.L.C.

v      Zhangjiakou DHA Pharmaceutical Company Limited

v      DSM Expert Centre BV

v      DSM Chemferm

v      DSM ZIBO Pharmaceuticals Company Limited

v      DSM Sourcing BV

v      DSM Composite Resins AG

v      DSM Neoresins BV

v      DSM Pharmaceutical Products INC.

v      DSM New Business Development BV

v      ZJK DSM Hayao Pharma

v      DSM Composite Research

v      DSM Venturing BV

v      Fersinsa GB, S.A.

v      DSM Engineering Plastics

v      DSM Innovation Center

v      DSM Business Support B.V.

v      DSM (China) Limited

v      DSM Nutritional Products, USA

v      DSM IT B.V.

v      DSM Biomedical

v      DSM Fine Chemicals, Austria

v      DSM Trading (Beijing) Company

v      DSM India Private Limited

v      DSM Services USA Inc.

v      DSM Desotech

v      Zhang Jia Kou GB Pharma Company Limited

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

170,000,000

Equity Shares

Rs. 10/- each

Rs. 1700.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

160,300,696

Equity Shares

Rs. 10/- each

Rs. 1603.010 Millions

 

 

 

 

 

 

Footnotes

 

(A) The company has only one class of equity shares having par value of Rs. 10 per share. Each holder of equity shares is entitled to one vote per share. The Company declares and pays dividends in Indian rupees. The dividend proposed by the Board of Directors is subject to the approval of the shareholders in the ensuing Annual General Meeting. However till date no dividend has been declared by Company. In the event of liquidation of the company, the holders of equity shares will be entitled to receive remaining assets of the company, after distribution of all preferential amounts. The distribution will be in proportion to the number of equity shares held by the shareholders.

 

 

(B) The company has only one class of equity shares having par value of Rs. 10 per share. Each holder of equity shares is entitled to one vote per share. The Company declares and pays dividends in Indian rupees. The dividend proposed by the Board of Directors is subject to the approval of the shareholders in the ensuing Annual General Meeting. However till date no dividend has been declared by Company. In the event of liquidation of the company, the holders of equity shares will be entitled to receive remaining assets of the company, after distribution of all preferential amounts. The distribution will be in proportion to the number of equity shares held by the shareholders.


FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2012

31.03.2011

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

1603.010

1603.010

(b) Reserves & Surplus

 

(395.170)

(303.590)

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

1207.840

1299.420

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

0.000

757.520

(b) Deferred tax liabilities (Net)

 

0.000

0.000

(c) Other long term liabilities

 

0.000

0.000

(d) long-term provisions

 

0.000

0.000

Total Non-current Liabilities (3)

 

0.000

757.520

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

572.830

446.000

(b) Trade payables

 

2453.090

2627.180

(c) Other current liabilities

 

903.150

98.870

(d) Short-term provisions

 

26.310

20.860

Total Current Liabilities (4)

 

3955.380

3192.910

 

 

 

 

TOTAL

 

5163.220

5249.850

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

1087.610

1190.390

(ii) Intangible Assets

 

0.500

0.000

(iii) Capital work-in-progress

 

27.620

5.530

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

0.000

0.000

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

39.390

40.390

(e) Other Non-current assets

 

0.000

0.000

Total Non-Current Assets

 

1155.120

1236.310

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

1222.590

1082.320

(c) Trade receivables

 

2291.080

2208.920

(d) Cash and cash equivalents

 

160.150

335.140

(e) Short-term loans and advances

 

323.290

362.450

(f) Other current assets

 

10.990

24.710

Total Current Assets

 

4008.100

4013.540

 

 

 

 

TOTAL

 

5163.220

5249.850

 

 

SOURCES OF FUNDS

 

 

 

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

1562.670

2] Share Application Money

 

 

0.000

3] Reserves & Surplus

 

 

48.790

4] (Accumulated Losses)

 

 

(345.660)

NETWORTH

 

 

1265.800

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

0.000

2] Unsecured Loans

 

 

1537.770

TOTAL BORROWING

 

 

1537.770

DEFERRED TAX LIABILITIES

 

 

0.000

 

 

 

 

TOTAL

 

 

2803.570

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

1275.550

Capital work-in-progress

 

 

7.090

 

 

 

 

INVESTMENT

 

 

0.000

DEFERREX TAX ASSETS

 

 

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 
 

823.890

 

Sundry Debtors

 
 

1471.850

 

Cash & Bank Balances

 
 

124.010

 

Other Current Assets

 
 

10.120

 

Loans & Advances

 
 

537.310

Total Current Assets

 
 

2967.180

Less : CURRENT LIABILITIES & PROVISIONS

 
 

 

 

Sundry Creditors

 
 

1350.550

 

Other Current Liabilities

 
 

75.960

 

Provisions

 
 

19.740

Total Current Liabilities

 
 

1446.250

Net Current Assets

 
 

1520.930

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.000

 

 

 

 

TOTAL

 

 

2803.570

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Income

8241.930

8624.080

6089.860

 

 

Other Income

33.770

104.320

106.090

 

 

TOTAL                                     (A)

8275.700

8728.400

6195.950

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Consumption materials changes inventories

7378.920

5171.370

 

 

Employee related expenses

 

301.520

278.890

 

 

Administrative selling other expenses

 

1038.820

840.130

 

 

TOTAL                                     (B)

8146.530

8719.260

6290.390

 

 

 

 

 

Less

PROFIT/ LOSS BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

129.170

9.160

9.140

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

99.580

96.750

96.730

 

 

 

 

 

 

PROFIT/ LOSS BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                               (E)

29.590

(87.590)

(87.590)

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

133.150

133.720

133.720

 

 

 

 

 

 

PROFIT/ LOSS BEFORE TAX (E-F)                    (G)

(103.560)

(221.310)

(221.310)

 

 

 

 

 

Less

TAX                                                                  (H)

(2.150)

36.060

36.050

 

 

 

 

 

 

PROFIT/ LOSS AFTER TAX (G-H)                     (I)

(101.410)

(257.370)

(257.360)

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export at FOB Value

3132.520

2977.840

2077.670

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

3919.940

2774.170

 

 

Traded Goods

 

485.690

397.310

 

 

Stores and Spare parts

 

3.260

2.290

 

 

Capital Items

 

0.520

14.510

 

 

Material In Transit

 

214.380

96.800

 

TOTAL IMPORTS

NA

4623.790

3285.080

 

 

 

 

 

 

Earnings/ Loss Per Share (Rs.)

(0.63)

(1.63)

(2.21)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

(1.23)

(2.95)

(5.58)

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

(1.26)

(2.54)

(5.66)

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

(2.02)

(4.22)

(8.13)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

(0.09)

(0.17)

(0.27)

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.47

0.93

1.21

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.01

1.26

2.05

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

No

24]

Banking facility details

No

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

UNSECURED LOANS

 

Unsecured Loans

31.03.2012

31.03.2011

 

 

(Rs. In Millions)

LONG-TERM BORROWINGS

 

 

Term loans from others

0.000

757.520

SHORT-TERM BORROWINGS

 

 

Rupee term loans from banks

313.140

446.000

Working capital loans from banks

259.690

0.000

Total

572.830

1203.520

 

 

Footnotes

 

LONG-TERM BORROWINGS

(A) Foreign Currency Term Loan from Gist Brocades International B.V., Netherlands (Holding Company) : 0

 

(B) Foreign Currency Term Loan from Gist Brocades International B.V., Netherlands (Holding Company) : 757.52 Foreign Currency Term Loan interest shall be calculated by reference to each period at a rate per annum equal to EURIBOR in relation to the relevant interest period plus the margin and shall be determined by the lender for each period on the interest determination date. Further the interest on loan shall be payable in each six months in arrears on 22nd February and 22nd August of each year. Subject to the terms of the agreement, the borrower shall repay the loan to the lender in full on 22nd February 2013.

 

SHORT-TERM BORROWINGS

(A) Out of Short term loan, loan of Rs.58.73 (previous year Nil) and Cash credit from bank is secured against the unconditional and irrecoverably bank guarantee of holding company i.e. "Koninklijke DSM N.V." for a maximum amount of EUR 10 Million Out of Short term loan, loan of Rs.254.40 is secured against pledge of deposits by DSM Finance B.V.(Belgium) for a maximum amount of USD 10 Million

 

 

 

CORPORATE INFORMATION

 

DSM Sinochem Pharmaceuticals India Private Limited (Formerly DSM Anti Infectives India Limited) (DSP) was established on February 4, 1993 as a Joint Venture between Gist Brocades NV, The Netherlands and Max India Limited. During the year 2002-03, it became a wholly owned subsidiary of Gist Brocades International B.V., Netherlands pursuant to exit of Max India Limited from the Joint Venture.

 

Company carries out the activities of development, production, purchase and sale of bulk drugs, which forms part of the operations under the Life Sciences cluster of the DSM Group.

 

 

FIXED ASSETS:

 

v      Land

v      Buildings

v      Plant and equipment

v      Furniture and fixtures

v      Vehicles

v      Office equipment

v      Leasehold improvements

v      Computer software


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 59.90

UK Pound

1

Rs. 90.88

Euro

1

Rs. 78.32

 

 

INFORMATION DETAILS

 

Information Gathered by :

PLV

 

 

Report Prepared by :

BVA

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTERS 

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

27

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.